Archives | LinksMedicus Free Medical News & Perspectives

Among patients 60+ with an intracapsular hip fracture, cemented hemiarthroplasty resulted in a modestly better quality of life and a lower risk of periprosthetic fracture than uncemented hemiarthroplasty. https://t.co/BKhd0PzXDr pic.twitter.com/8fqx5HbITN

— NEJM (@NEJM) February 9, 2022

M-A: The prevalence of loneliness across 113 countries.

10 Feb, 2022 | 10:08h | UTC

The prevalence of loneliness across 113 countries: systematic review and meta-analysis – The BMJ

Editorial: We need a public health approach to loneliness

News Release: Problematic levels of loneliness widespread in many countries – BMJ

Commentary on Twitter

https://twitter.com/robert_eres/status/1491663838013702144

Clinical Review: Advances in the management of cardioembolic stroke associated with patent foramen ovale.

10 Feb, 2022 | 10:17h | UTC

Advances in the management of cardioembolic stroke associated with patent foramen ovale – The BMJ

Patent Foramen Ovale (PFO) After Stroke: Meta-analysis suggests the application of a multivariable causal classification system may better distinguish patient subgroups who may benefit from PFO closure from those unlikely to receive benefit.

Management of the Patient With Patent Foramen Ovale in 2021: A Spectrum of Cases

Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology – Neurology

AHA Scientific Statement: Identifying best practices to improve evaluation and management of in-hospital stroke.

10 Feb, 2022 | 10:13h | UTC

Identifying Best Practices to Improve Evaluation and Management of In-Hospital Stroke: A Scientific Statement From the American Heart Association – Stroke

News Release: Five elements to optimize treatment of in-hospital stroke – American Heart Association

Commentary on Twitter

Identifying Best Practices to Improve Evaluation and Management of In-Hospital #Stroke: A Scientific Statement From the American Heart Association #AHAJournals #ISC22 https://t.co/e6zcLMeyBZ @American_Heart @AHAScience pic.twitter.com/eBgLc7OrBK

— Stroke AHA/ASA (@StrokeAHA_ASA) February 9, 2022

Sweden ends COVID-19 testing as pandemic restrictions lifted – “only health care and elderly care workers and the most vulnerable will be entitled to free PCR testing if they are symptomatic, while the rest of the population will simply be asked to stay home if they show symptoms that could be COVID-19”.

10 Feb, 2022 | 10:07h | UTC

Sweden ends COVID-19 testing as pandemic restrictions lifted – Associated Press

How Denmark Decided COVID Isn’t a Critical Threat to Society – “The country became the first in the EU to lift all COVID restrictions despite leading the world in per capita infections”.

Covid: Europe set for ‘long period of tranquillity’ in pandemic, says WHO.

As Denmark scraps COVID restrictions, WHO urges caution.

Despite the ongoing spread of Omicron, some European countries have decided to lift Covid-19 restrictions.

Clinical practice guideline on tympanostomy tubes in children.

10 Feb, 2022 | 10:10h | UTC

Executive Summary of Clinical Practice Guideline on Tympanostomy Tubes in Children (Update) – Otolaryngology–Head and Neck Surgery

A population-based study in Qatar showed previous infection provided robust protection against reinfection with the alpha, beta, and delta variants of SARS-CoV-2 (approximately 90%). However, protection against reinfection with the omicron variant was lower (around 60%).

10 Feb, 2022 | 10:04h | UTC

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection – New England Journal of Medicine

Commentary on Twitter

Using a national database in Qatar, investigators found that previous #SARSCoV2 infection provided protection against reinfection that ranged from 85% to 92% for alpha, beta, and delta strains and was approx 60% protective against omicron. #COVID19 https://t.co/SGODYCmkP3 pic.twitter.com/OkgjCbyZBj

— NEJM (@NEJM) February 9, 2022

RCT: Final analysis of efficacy and safety of single-dose J&J vaccine.

10 Feb, 2022 | 10:03h | UTC

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S – New England Journal of Medicine

Commentary on Twitter

A single injection of the Ad26.COV2.S Covid-19 vaccine showed 56.3% vaccine efficacy beginning 14 days after injection and 52.9% efficacy more than 28 days after injection against moderate to severe–critical #COVID19. #IDTwitter https://t.co/0VhaEUtmwq pic.twitter.com/04QqSyYwNI

— NEJM (@NEJM) February 9, 2022

Vaccine effectiveness of heterologous CoronaVac plus Pfizer in Brazil.

10 Feb, 2022 | 10:01h | UTC

Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil – Nature Medicine

Commentary on Twitter

An analysis of data from Brazil in @NatureMedicine shows that vaccine effectiveness against SARS-CoV-2 infection and severe COVID-19 outcomes declines after two doses of CoronaVac but increases after a booster dose of the Pfizer-BioNTech vaccine. https://t.co/UCgy6cJFIP pic.twitter.com/pXvkxZHXvv

— Nature Portfolio (@NaturePortfolio) February 9, 2022

Stay Updated in Your Specialty